ID   NLEB1_ECO57             Reviewed;         329 AA.
AC   Q8XBX8; A0A0H3JHS6; A0A6M0JF43; Q7AAV0;
DT   02-JUN-2021, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   28-JAN-2026, entry version 133.
DE   RecName: Full=Protein-arginine N-acetylglucosaminyltransferase NleB1 {ECO:0000305};
DE            Short=Arginine GlcNAcyltransferase NleB1 {ECO:0000305};
DE            EC=2.4.1.- {ECO:0000269|PubMed:30619781};
DE   AltName: Full=Non-LEE-encoded type III effector B1 {ECO:0000303|PubMed:30619781};
GN   Name=nleB1 {ECO:0000303|PubMed:30619781};
GN   OrderedLocusNames=ECs3857 {ECO:0000312|EMBL:BAB37280.1};
OS   Escherichia coli O157:H7.
OC   Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria;
OC   Enterobacterales; Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83334;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=O157:H7 / Sakai / RIMD 0509952 / EHEC;
RX   PubMed=11258796; DOI=10.1093/dnares/8.1.11;
RA   Hayashi T., Makino K., Ohnishi M., Kurokawa K., Ishii K., Yokoyama K.,
RA   Han C.-G., Ohtsubo E., Nakayama K., Murata T., Tanaka M., Tobe T., Iida T.,
RA   Takami H., Honda T., Sasakawa C., Ogasawara N., Yasunaga T., Kuhara S.,
RA   Shiba T., Hattori M., Shinagawa H.;
RT   "Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and
RT   genomic comparison with a laboratory strain K-12.";
RL   DNA Res. 8:11-22(2001).
RN   [2]
RP   FUNCTION.
RC   STRAIN=O157:H7 / Sakai / RIMD 0509952 / EHEC;
RX   PubMed=28522607; DOI=10.1074/jbc.m117.790675;
RA   El Qaidi S., Chen K., Halim A., Siukstaite L., Rueter C.,
RA   Hurtado-Guerrero R., Clausen H., Hardwidge P.R.;
RT   "NleB/SseK effectors from Citrobacter rodentium, Escherichia coli, and
RT   Salmonella enterica display distinct differences in host substrate
RT   specificity.";
RL   J. Biol. Chem. 292:11423-11430(2017).
RN   [3]
RP   CATALYTIC ACTIVITY, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES, ACTIVITY
RP   REGULATION, AND MUTAGENESIS OF 221-ASP--ASP-223.
RC   STRAIN=O157:H7 / Sakai / RIMD 0509952 / EHEC;
RX   PubMed=30619781; DOI=10.3389/fcimb.2018.00435;
RA   El Qaidi S., Zhu C., McDonald P., Roy A., Maity P.K., Rane D., Perera C.,
RA   Hardwidge P.R.;
RT   "High-throughput screening for bacterial glycosyltransferase inhibitors.";
RL   Front. Cell. Infect. Microbiol. 8:435-435(2018).
CC   -!- FUNCTION: Protein-arginine N-acetylglucosaminyltransferase effector
CC       that disrupts TNF signaling in infected cells, including NF-kappa-B
CC       signaling, apoptosis and necroptosis (PubMed:28522607). Acts by
CC       catalyzing the transfer of a single N-acetylglucosamine (GlcNAc) to a
CC       conserved arginine residue in the death domain of host proteins such as
CC       FADD: arginine GlcNAcylation prevents homotypic/heterotypic death
CC       domain interactions and assembly of the oligomeric TNF receptor
CC       complex, thereby disrupting TNF signaling (PubMed:28522607). Also acts
CC       on host proteins without a death domain: catalyzes arginine
CC       GlcNAcylation of host GAPDH protein, thereby preventing GAPDH
CC       interaction with TRAF2, leading to inhibit NF-kappa-B signaling
CC       (PubMed:28522607). Catalyzes auto-GlcNAcylation, which is required for
CC       activity toward death domain-containing host target proteins (By
CC       similarity). {ECO:0000250|UniProtKB:B7UI21,
CC       ECO:0000269|PubMed:28522607}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-arginyl-[protein] + UDP-N-acetyl-alpha-D-glucosamine =
CC         N(omega)-(N-acetyl-beta-D-glucosaminyl)-L-arginyl-[protein] + UDP +
CC         H(+); Xref=Rhea:RHEA:66632, Rhea:RHEA-COMP:10532, Rhea:RHEA-
CC         COMP:17079, ChEBI:CHEBI:15378, ChEBI:CHEBI:29965, ChEBI:CHEBI:57705,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:167322;
CC         Evidence={ECO:0000269|PubMed:30619781};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66633;
CC         Evidence={ECO:0000269|PubMed:30619781};
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:30619781};
CC   -!- ACTIVITY REGULATION: Protein-arginine N-acetylglucosaminyltransferase
CC       activity is inhibited by 100066N compound (flavone analog) and 102644N
CC       compound (a substituted isoxazole). {ECO:0000269|PubMed:30619781}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=379 uM for UDP-N-acetyl-alpha-D-glucosamine
CC         {ECO:0000269|PubMed:30619781};
CC         Note=kcat is 50 sec(-1) with UDP-N-acetyl-alpha-D-glucosamine
CC         substrate. {ECO:0000269|PubMed:30619781};
CC   -!- INTERACTION:
CC       Q8XBX8; Q14244: MAP7; Xeno; NbExp=4; IntAct=EBI-10039153, EBI-2211064;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:A0A482PDI9}. Host
CC       cytoplasm {ECO:0000250|UniProtKB:B7UI21}. Note=Secreted via the type
CC       III secretion system (T3SS). {ECO:0000250|UniProtKB:A0A482PDI9}.
CC   -!- DOMAIN: Adopts a GT-A fold and acts as an inverting enzyme that
CC       converts the alpha-configuration in the UDP-N-acetyl-alpha-D-
CC       glucosamine donor to the beta configuration in the N-linked (GlcNAc)
CC       arginine product. {ECO:0000250|UniProtKB:B7UI21}.
CC   -!- PTM: Auto-glycosylated: arginine GlcNAcylation is required for activity
CC       toward death domain-containing host target proteins.
CC       {ECO:0000250|UniProtKB:B7UI21}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase NleB family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BA000007; BAB37280.1; -; Genomic_DNA.
DR   RefSeq; NP_311884.1; NC_002695.1.
DR   RefSeq; WP_000953022.1; NZ_AP018488.1.
DR   AlphaFoldDB; Q8XBX8; -.
DR   SMR; Q8XBX8; -.
DR   IntAct; Q8XBX8; 4.
DR   STRING; 155864.Z4328; -.
DR   GlyCosmos; Q8XBX8; 4 sites, No reported glycans.
DR   GeneID; 916317; -.
DR   KEGG; ecs:ECs_3857; -.
DR   PATRIC; fig|386585.9.peg.4025; -.
DR   eggNOG; ENOG502Z8RE; Bacteria.
DR   HOGENOM; CLU_081850_0_0_6; -.
DR   OMA; PIRTICH; -.
DR   Proteomes; UP000000558; Chromosome.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0030430; C:host cell cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0030145; F:manganese ion binding; IDA:UniProtKB.
DR   GO; GO:0106362; F:protein-arginine N-acetylglucosaminyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR   GO; GO:0052038; P:symbiont-mediated perturbation of host intracellular transport; IMP:AgBase.
DR   InterPro; IPR057545; SseK_NleB.
DR   NCBIfam; NF011909; PRK15382.1; 1.
DR   Pfam; PF24688; SseK_NleB; 1.
PE   1: Evidence at protein level;
KW   Glycoprotein; Glycosyltransferase; Host cytoplasm; Manganese;
KW   Metal-binding; Reference proteome; Secreted; Toxin; Transferase; Virulence.
FT   CHAIN           1..329
FT                   /note="Protein-arginine N-acetylglucosaminyltransferase
FT                   NleB1"
FT                   /id="PRO_0000452592"
FT   MOTIF           221..223
FT                   /note="DXD motif"
FT                   /evidence="ECO:0000305"
FT   ACT_SITE        253
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:B7UI21"
FT   BINDING         48..50
FT                   /ligand="UDP-N-acetyl-alpha-D-glucosamine"
FT                   /ligand_id="ChEBI:CHEBI:57705"
FT                   /evidence="ECO:0000250|UniProtKB:B7UI21"
FT   BINDING         72
FT                   /ligand="UDP-N-acetyl-alpha-D-glucosamine"
FT                   /ligand_id="ChEBI:CHEBI:57705"
FT                   /evidence="ECO:0000250|UniProtKB:B7UI21"
FT   BINDING         219..222
FT                   /ligand="UDP-N-acetyl-alpha-D-glucosamine"
FT                   /ligand_id="ChEBI:CHEBI:57705"
FT                   /evidence="ECO:0000250|UniProtKB:B7UI21"
FT   BINDING         223
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250|UniProtKB:B7UI21"
FT   BINDING         320
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250|UniProtKB:B7UI21"
FT   BINDING         322
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250|UniProtKB:B7UI21"
FT   BINDING         322
FT                   /ligand="UDP-N-acetyl-alpha-D-glucosamine"
FT                   /ligand_id="ChEBI:CHEBI:57705"
FT                   /evidence="ECO:0000250|UniProtKB:B7UI21"
FT   BINDING         327..329
FT                   /ligand="UDP-N-acetyl-alpha-D-glucosamine"
FT                   /ligand_id="ChEBI:CHEBI:57705"
FT                   /evidence="ECO:0000250|UniProtKB:B7UI21"
FT   CARBOHYD        13
FT                   /note="N-beta-linked (GlcNAc) arginine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:B7UI21"
FT   CARBOHYD        53
FT                   /note="N-beta-linked (GlcNAc) arginine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:B7UI21"
FT   CARBOHYD        159
FT                   /note="N-beta-linked (GlcNAc) arginine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:B7UI21"
FT   CARBOHYD        293
FT                   /note="N-beta-linked (GlcNAc) arginine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:B7UI21"
FT   MUTAGEN         221..223
FT                   /note="DAD->AAA: Abolished protein-arginine
FT                   N-acetylglucosaminyltransferase activity."
FT                   /evidence="ECO:0000269|PubMed:30619781"
SQ   SEQUENCE   329 AA;  37643 MW;  4345B8A5B037A195 CRC64;
     MLSSLNVLQS SFRGKTALSN STLLQKVSFA GKEYPLEPID EKTPILFQWF EARPERYEKG
     EVPILNTKEH PYLSNIINAA KIENERIIGV LVDGNFTYEQ KKEFLSLENE YQNIKIIYRA
     DVDFSMYDKK LSDIYLENIH KQESYPASER DNYLLGLLRE ELKNIPEGKD SLIESYAEKR
     EHTWFDFFRN LAMLKAGSLF TETGKTGCHN ISPCSGCIYL DADMIITDKL GVLYAPDGIA
     VHVDCNDEIK SLENGAIVVN RSNHPALLAG LDIMKSKVDA HPYYDGLGKG IKRHFNYSSL
     HDYNAFCDFI EFKHENIIPN TSMYTCSSW
//
